Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease.

Categoría Estudio primario
RevistaThe New England journal of medicine
Año 2005
Cargando información sobre las referencias
The prior diagnosis of fatal astrocytoma in a 60-year-old man with Crohn's disease treated with natalizumab, a monoclonal antibody against alpha4 integrins, was reclassified as JC virus-related progressive multifocal leukoencephalopathy (PML). Analysis of frozen serum samples showed that JC virus DNA had appeared in the serum three months after the initiation of open-label natalizumab monotherapy and two months before the appearance of symptomatic PML. There was staining of the brain lesion for polyomavirus. This case report, along with two others, suggests that anti-alpha4-integrin therapy can result in JC virus-induced PML.
Epistemonikos ID: 44882d45539fc411ae381ee7bc28a75d159118d7
First added on: Oct 05, 2014